HealthMore in Health→
Insilico and Lilly Put Another Big Number on AI Drugmaking
Key Takeaways
- Candidate metadata says Lilly signed a commercialization deal with Insilico Medicine.
- The agreement includes $115 million upfront.
- The total potential value is approximately $2.75 billion.
DE
DT Editorial Team··via statnews.com